Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Marshall

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Molecular Plant|January 15, 2022
The RppC-AvrRppC NLR-effector interaction mediates the resistance to southern corn rust in maizeCe Deng, April Leonard, James Cahill, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2026
Targeted knockout of a host peroxisomal peptidase confers field resistance to maize lethal necrosisMark Jung, Zhengyu Wen, Sabrina Humbert, et al.
Journal of Medicinal Chemistry|September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Molecular Plant|January 15, 2022
The RppC-AvrRppC NLR-effector interaction mediates the resistance to southern corn rust in maizeCe Deng, April Leonard, James Cahill, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2026
Targeted knockout of a host peroxisomal peptidase confers field resistance to maize lethal necrosisMark Jung, Zhengyu Wen, Sabrina Humbert, et al.
Journal of Medicinal Chemistry|September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.
Pageof 11